Jeronimo Martins

JERONIMO’S ALL SET FOR THE NEXT LEAP! (ADD; 19% UPSIDE)

22/03/23 -" Summary: Despite near-term challenges, Jeronimo Martins remains one of the healthiest companies in the sector. Inflation and recession fears will continue to put pressure on the industry, but JMT's ..."

PDF page sample
Pages
58
Language
English
Published on
22/03/23
Download
You may also be interested by these reports :
02/06/23
The Rebound Of European Grocers : Fluke Or Fundamentally Driven?
01/06/23
Casino is grappling with multiple issues in France. The grocer is losing market share due to uncompetitive pricing (a poor showing especially in ...
12/05/23
2Q22/23 results exceeded expectations; FY22/23E outlook confirmed
11/05/23
Ahold Delhaize’s Q1 performance was slightly ahead of our as well as the market’s expectations. Group comparable sales (excluding gasoline) grew by ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO